For instance, the prostate-specific antigen promoter33, carcinoembryonic antigen (CEA) promoter34, survivin19, mucin-1 promoter (for breast cancer), and mesothelin promoter (for ovarian cancer) have been widely employed to specifically detect these individual cancers35. This evidence concerns the gene MSLN and breast carcinoma.